Short-term triple therapy with azithromycin for Helicobacter pylori eradication
Author Information
Author(s): Silva Fernando M, Eisig Jaime N, Teixeira Ana Cristina S, Barbuti Ricardo C, Navarro-Rodriguez Tomás, Mattar Rejane
Primary Institution: Serviço de Gastroenterologia Clínica, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
Hypothesis
The study aimed to verify the efficacy of H. pylori eradication using azithromycin, amoxicillin, and omeprazole in patients with peptic ulcer disease.
Conclusion
Despite its low cost and high compliance, the low eradication rate does not allow the recommendation of the triple therapy with azithromycin as an adequate treatment for H. pylori infection.
Supporting Evidence
- The eradication rate was 38% per intention to treat and 41% per protocol.
- Few adverse effects were observed and treatment compliance was high.
- Patients were considered cured when they presented negative results in at least two of the performed tests.
Takeaway
The study tested a cheap treatment for a stomach bug but found it didn't work very well, even though people took it easily.
Methodology
Patients with peptic ulcer and H. pylori infection were treated for six days with azithromycin, amoxicillin, and omeprazole, followed by eradication control 12 weeks later.
Limitations
The low eradication rates and the study's design may limit the generalizability of the findings.
Participant Demographics
{"mean_age":48,"age_range":"21-83","sex_distribution":{"women":31,"men":29},"peptic_ulcer_risk_factors":{"smokers":21,"NSAID_users":16}}
Statistical Information
Confidence Interval
95%
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website